Though CD19-/CD45+ cells have been found to represent CSC characteristics in MCL tumors, no such molecular features of CSCs have been identified in DLBCL tumors [47], possibly due to the different histological makeup. This evidence concerns the gene CD19 and mantle cell lymphoma.